Safety and Efficacy of Single-Dose Fluconazole Compared with a 7-Day Regimen of Itraconazole in the Treatment of AIDS-Related Oropharyngeal Candidiasis

1998 ◽  
Vol 26 (3) ◽  
pp. 159-170 ◽  
Author(s):  
S De Wit ◽  
E O'Doherty ◽  
C De Vroey ◽  
N Clumeck
Keyword(s):  
Single Dose ◽  
Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
Oropharyngeal Candidiasis ◽  
Open Label ◽  
Lower Response Rate ◽  
Immunodeficiency Virus ◽  
Concomitant Medications ◽  
To Receive

The primary aim of this study was to compare the efficacy and safety of single-dose fluconazole and a 7-day regimen of itraconazole for the treatment of oropharyngeal candidiasis in human immunodeficiency virus (HlV)-positive patients. In this open-label trial, 40 HIV-positive patients with oropharyngeal candidiasis were randomized to receive either one dose of fluconazole 150 mg or seven daily doses of itraconazole 100 mg. Clinical condition was assessed at baseline, day 8, and day 30 (follow-up). In the fluconazole group, 15 of 20 (75%) patients were clinically cured on day 8, three (15%) were clinically improved, and two (10%) were treatment failures. At follow-up, six (30%) patients experienced relapse. In the itraconazole group, four of 17 (24%) patients were clinically cured at 8 days, and two (12%) were clinically improved; two patients relapsed by day 30. Ten (50%) patients in the itraconazole group were taking concomitant medications that could potentially affect the bioavailability of itraconazole. After excluding the results from these patients, clinical response rates remained significantly higher in the fluconazole treatment arm. These results suggest that a single 150-mg dose of fluconazole may be a safe, effective, and convenient therapy for acquired immune deficiency syndrome-related oropharyngeal candidiasis. The lower response rate in the patients who received itraconazole 100 mg daily for 7 days could be explained by drug interactions and the unpredictable absorption of itraconazole.

scholarly journals A trend analysis of people living with human immunodeficiency virus attending an anti-retroviral therapy centre in urban Bangalore

2021 ◽  
Vol 8 (11) ◽  
pp. 5279
Author(s):  
Ramesh Masthi N. R. ◽  
Divya Bharathi G. ◽  
Pruthvi S.
Keyword(s):  
Human Immunodeficiency Virus ◽  
Public Health Problem ◽  
Control Program ◽  
Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
Major Public Health Problem ◽  
Immunodeficiency Virus ◽  
Lost To Follow Up ◽  
Acquired Immune Deficiency

Background: HIV infection in India is a major public health problem. The anti-retroviral therapy (ART) centre is the backbone of the national acquired immune deficiency syndrome (AIDS) control program (NACO). To assess the trend of new people living with human immunodeficiency virus (PLHIV) registered at an ART centre in Bangalore and their treatment status.Methods: All the PLHIV registered at an ART centre from 1st January, 2009 to 31st December, 2018 were included in the study. PLHIV registered but not initiated on treatment, were excluded.Results: Out of 4428 PLHIV registered at an ART centre, 2964 were initiated on treatment. The youngest PLHIV registered was 6 years, oldest was 79 years and the decadal median age was 38 years. Majority (41.4%) were in the age group of 31 to 40 years. Predominant gender was male. A declining trend of new PLHIV, LFU/stopped/missed cases over the past decade was observed. The 1658 are alive, 402 died, 305 cases either missed, stopped or lost to follow up, 32 cases were opted out of the treatment and 567 cases were transferred out.Conclusions: A decline in number of new PLHIV, LFU, missed and stopped over the decade was observed.

Widespread use of herbal medicines by people living with human immunodeficiency virus and contamination of herbal medicines with antiretrovirals in Nigeria

2018 ◽  
Vol 30 (4) ◽  
pp. 371-377
Author(s):  
J Gini ◽  
A Amara ◽  
Sujan D Penchala ◽  
David J Back ◽  
L Else ◽  
...  
Keyword(s):  
Mass Spectrometry ◽  
Human Immunodeficiency Virus ◽  
Herbal Medicine ◽  
Herbal Medicines ◽  
Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
Medicine Use ◽  
Street Vendors ◽  
Hiv Therapy ◽  
Immunodeficiency Virus

Herbal medication use amongst people living with human immunodeficiency virus (PLWH) is widespread and understudied. This study aimed to evaluate the prevalence of herbal medicine use amongst PLWH and possible contamination with antiretrovirals (ARVs). Countrywide collection of herbal samples sold by street vendors in Nigeria for the following indications: human immunodeficiency virus (HIV), acquired immune deficiency syndrome, fever and general weakness. Samples were screened using a validated liquid chromatography-mass spectrometry/mass spectrometry method for the presence of the following ARVs: efavirenz, nevirapine, lopinavir, darunavir, ritonavir, atazanavir, emtricitabine, tenofovir and lamivudine. A survey was conducted among 742 PLWH attending four HIV clinics in Nigeria. Data were collected using a structured questionnaire and analysed using IBM SPSS statistics version 22.0 (IBM Corp., 2013, Armond, NY). Of the 138 herbal medicines sampled, three (2%) contained detectable levels of tenofovir, emtricitabine and/or lamivudine. Additionally, of the 742 PLWH surveyed, 310 (41.8%) reported herbal medicine use. Among the users, 191 (61.6%) started taking herbals after commencing HIV therapy while herbal medicine use preceded ARVs treatment in 119 (38.4%) PLWH. We found herbal use to be widespread among PLWH in Nigeria, with increasing use after commencing ARV. Three herbal preparations were also found to contain detectable levels of ARVs. This is a concern and should be studied widely across the region and countries where herbal medicine use is prevalent and poorly regulated.

scholarly journals Knowledge, Attitudes and Practices Regarding Pre-Exposure Prophylaxis (PrEP) in a Sample of Italian Men Who Have SEX with MEN (MSM)

2021 ◽  
Vol 18 (9) ◽  
pp. 4772
Author(s):  
Gianluca Voglino ◽  
Maria Rosaria Gualano ◽  
Stefano Rousset ◽  
Pietro Forghieri ◽  
Isabella Fraire ◽  
...  
Keyword(s):  
Online Survey ◽  
Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
Attitudes And Practices ◽  
Immunodeficiency Virus ◽  
Sex With Men ◽  
Prep Awareness ◽  
Exposure Prophylaxis ◽  
The Cost ◽  
Knowledge Attitudes And Practices

Background: Pre-exposure prophylaxis (PrEP) is suitable for high human immunodeficiency virus (HIV)-infection risk people, foremost among whom are males who have sex with other males (MSM). This study evaluated knowledge, attitudes and practices regarding PrEP in a sample of Italian MSM, in order to hypothesize strategies to implement PrEP awareness and use. No previous study has assessed this issue; Methods: An online survey was given to an opportunistic sample of Italian MSM. The questionnaire investigated sexual behaviour and habits, HIV/acquired immune deficiency syndrome (AIDS) knowledge and PrEP awareness, attitudes and practices. Univariable and multivariable logistic regressions were conducted to identify factors associated with PrEP knowledge; Results: A total of 196 MSM participated in this survey. Overall data showed that 87.2% of participants knew what PrEP is, but only 7.5% have ever used it. The main reason for not using PrEP was the cost of the therapy (26.9%). The principal source of PrEP information was the Internet (68.4%). Being regularly tested for HIV was significantly associated with PrEP knowledge (adjusted odds ratio (AdjOR) = 3.16; confidence interval (CI) = 1.06–9.29); Conclusions: Knowledge regarding PrEP was well established, but PrEP use was not equally widespread. It is necessary to improve research on PrEP usage in order to PrEP access to be granted.

scholarly journals The origin of acquired immune deficiency syndrome: Darwinian or Lamarckian?

2001 ◽  
Vol 356 (1410) ◽  
pp. 877-887 ◽  
Author(s):  
Tom Burr ◽  
J. M. Hyman ◽  
Gerald Myers
Keyword(s):  
Immune Deficiency ◽  
Simulated Data ◽  
Immune Deficiency Syndrome ◽  
Acquired Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
Darwinian Evolution ◽  
Immunodeficiency Virus ◽  
Acquired Immune Deficiency ◽  
Hiv 1

The subtypes of human immunodeficiency virus type 1 (HIV–1) group M exhibit a remarkable similarity in their between–subtype distances, which we refer to as high synchrony. The shape of the phylogenetic tree of these subtypes is referred to as a sunburst to distinguish it from a simple star phylogeny. Neither a sunburst pattern nor a comparable degree of symmetry is seen in a natural process such as in feline immunodeficiency virus evolution. We therefore have undertaken forward–process simulation studies employing coalescent theory to investigate whether such highly synchronized subtypes could be readily produced by natural Darwinian evolution. The forward model includes both classical (macro) and molecular (micro) epidemiological components. HIV–1 group M subtype synchrony is quantified using the standard deviation of the between–subtype distances and the average of the within–subtype distances. Highly synchronized subtypes and a sunburst phylogeny are not observed in our simulated data, leading to the conclusion that a quasi–Lamarckian, punctuated event occurred. The natural transfer theory for the origin of human acquired immune deficiency syndrome (AIDS) cannot easily be reconciled with these findings and it is as if a recent non–Darwinian process took place coincident with the rise of AIDS in Africa.

Operation “Denver”

2021 ◽  
Vol 23 (3) ◽  
pp. 4-80
Author(s):  
Douglas Selvage
Keyword(s):  
Immune Deficiency Syndrome ◽  
Deficiency Syndrome ◽  
West Germany ◽  
Soviet Leader ◽  
Mikhail Gorbachev ◽  
State Security ◽  
Intelligence Services ◽  
Immunodeficiency Virus ◽  
East German ◽  
Acquired Immune Deficiency

Abstract This second part of a two-part article moves ahead in showing how the East German Ministry for State Security (Stasi) came to play a key role in the disinformation campaign launched by the Soviet State Security Committee (KGB) in 1983 regarding the origins of the Human Immunodeficiency Virus (HIV) and the Acquired Immune Deficiency Syndrome (AIDS). The KGB launched the campaign itself, but in the mid-1980s it sought to widen the effort by enlisting the cooperation of intelligence services in other Warsaw Pact countries, especially the Stasi. From the autumn of 1986 until November 1989, the Stasi played a central role in the disinformation campaign. Despite pressure from the U.S. government and a general inclination of Soviet leader Mikhail Gorbachev to curtail the campaign by the end of 1987, both the KGB and the USSR's official Novosti press agency continued until 1989 to spread false allegations that HIV was a U.S. biological weapon. Even after the KGB curtailed its disinformation in 1989, the Stasi continued to disseminate falsehoods, not least because it had successfully maintained plausible deniability regarding its role in the campaign. The Stasi worked behind the scenes to support the work of Soviet–East German scientists Jakob Segal and Lilli Segal and to facilitate dissemination of the Segals’ views in West Germany and Great Britain, especially through the leftwing media, and to purvey broader disinformation about HIV/AIDS by attacking U.S. biological and chemical weapons in general.

Sign in / Sign up

Export Citation Format

Share Document